Fact-check: “how likely is keytruda to cause sarcoidosis”
Verdict: Partly True (62% confidence)
Evidence documents that Keytruda (pembrolizumab) is associated with sarcoidosis and sarcoid-like reactions (SLRs) as a recognized immune-mediated adverse event, listed in FDA labeling at less than 1% incidence, with a melanoma-focused systematic review reporting SLR prevalence of 1.5%–1.8%. However, the claim as posed cannot be answered with a single precise probability because incidence estimates vary by cancer type, regimen, and how strictly sarcoidosis versus sarcoid-like reaction is defined…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Pete hegseth uses cocaine — Unverifiable
- Pete hegseth is a drunk — Partly True
- September is a good time to see whales in the waters around Greenland — True
- In 1979 America was ranked #1 in education and 46 years later we are ranked #40 — False
- Over 1000 people are killed by US police every year. — Mostly True